Cadrenal Therapeutics, Inc. Common Stock (CVKD)
Cadrenal Therapeutics, Inc. Common Stock (CVKD) has reported earnings 13 times since May 10, 2023. The stock moves an average of ±4.53% the day after reporting, closing higher 69.2% of the time. Its largest post-earnings gain was +17.67% (Nov 07, 2024) and its largest decline was -9.42% (May 10, 2023). The next earnings report is predicted for 2026-11-06 (estimated).
Earnings reactions
How CVKD moved on each past earnings report.
Earnings Impact
Total Earnings
13
Avg Abs. Movement
±4.53%
Positive %
69.2%
Negative %
30.8%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 13, 2026 | ☽ POST | +0% | open_in_new |
| May 07, 2026 | ☀ PRE | +1.57% | open_in_new |
| Mar 31, 2026 | ☀ PRE | +15.09% | open_in_new |
| Nov 10, 2025 | ☀ PRE | -7.57% | open_in_new |
Earnings Count
13
Total earnings in dataset
Avg Abs. Movement
±4.53%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| S-8 | 20260903 | open_in_new SEC.gov |
| 8-K | 20260831 | open_in_new SEC.gov |
| 10-Q | 20260813 | open_in_new SEC.gov |
| 8-K | 20260813 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260807 | open_in_new SEC.gov |
| ARS | 20260803 | open_in_new SEC.gov |
| DEF 14A | 20260803 | open_in_new SEC.gov |
| DEFA14A | 20260803 | open_in_new SEC.gov |
| PRE 14A | 20260723 | open_in_new SEC.gov |
| 8-K | 20260721 | open_in_new SEC.gov |
Frequently asked about CVKD earnings
When does Cadrenal Therapeutics, Inc. Common Stock report earnings next? expand_more
Cadrenal Therapeutics, Inc. Common Stock (CVKD)'s next earnings date is estimated for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does CVKD stock move after earnings? expand_more
Over 13 reports, CVKD has moved an average of ±4.53% the session after earnings, closing higher 69.2% of the time.
What was CVKD's biggest post-earnings move? expand_more
CVKD's largest post-earnings gain on record was +17.67% on Nov 07, 2024, and its largest decline was -9.42% on May 10, 2023.
Where can I find Cadrenal Therapeutics, Inc. Common Stock's SEC filings? expand_more
All of Cadrenal Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right